Profile analysis of N4-acetylcytidine (ac4C) on mRNA of human lung adenocarcinoma and paired adjacent non-tumor tissues

• Published in: Biochimica et biophysica acta. General subjects Vol. 1867; no. 12; p. 130498
• Main Authors: Shang, Xingchen, Peng, Ying, Wang, Yancheng, Feng, Zhen, Li, Meng, Peng, Zhongmin, Ren, Wangang
• Format: Journal Article
• Language: English
• Published: Netherlands 01.12.2023
• Subjects: acetylation; adenocarcinoma; Adenocarcinoma of Lung - genetics; bioinformatics; Cytidine; enzymes; genetic markers; Humans; immunohistochemistry; lung neoplasms; Lung Neoplasms - genetics; lungs; microarray technology; precipitin tests; RNA; species; sumoylation; acRIP-seq; mRNA; Lung adenocarcinoma; ac4C; N4-acetylcytidine
• ISSN: 0304-4165; 1872-8006; 1872-8006
• DOI: 10.1016/j.bbagen.2023.130498

RNA modification, a major component of post-transcriptional modification, plays an essential role in tumor initiation and progression. N4-acetylcytidine (ac4C) present in different species as a highly conserved RNA modification. ac4C on mRNA increases the stability of mRNA and the efficiency of protein translation. However, the mRNA profiling of ac4C in lung adenocarcinoma (LUAD) is unknown. NAT10 expression was tested using immunohistochemistry in tissue microarray (TMA). The ac4C peaks on mRNA were identified through acetylated RNA immunoprecipitation sequencing in both human LUAD tissues and adjacent non-tumor tissues, and differences of acetylation and mRNA between the two groups were analyzed. Furthermore, the function of AC4C-specific acetylated transcripts was analyzed bioinformatically. And a ac-RIP-PCR was used to verify the ac4C acetylation sites of TFAP2A. The expression of acetylated key enzyme NAT10 was obviously increased in LUAD group. Then we found noticeable differences in ac4C mRNA modification between LUAD and adjacent non-tumor tissues. In addition, bioinformatics analysis showed that the distinctive distribution pattern of mRNA ac4C in LUAD affects a variety of cellular functions, such as protein sumoylation and transmembrane transporter activity. Importantly, we verified the ac4C level of TFAP2A was up-regulated in LUAD. Our study revealed that the degree of ac4C in mRNA in LUAD was significantly higher than in adjacent tissues and was concentrated mainly in the coding sequences with a implications in a wide range of cellular functions. The ac4C may become a new molecular marker and treatment target for lung cancer.